5Giacio JT, Zasler ND, Katz DI, et al. Development of Prac- tice guidelines for assessment and management of the vege- tative and minimally conscious states [J]. J Head Trauma Rehabil, 1997, 12(4): 79-89.
6Seo S, Engulund JA, Nguyen JT, et al. Combination therapy with amantadine, oseltamivir and ribavirinfor influenza A infection: safety and pharmacokinetics [J]. Antivir Ther, 2013, 18(3): 377-386.
7Quarato G, Scrima R, Ripoli M, et al. Protective role of amantadine in mitochondrial dysfunction and oxidative stress mediated by hepatitis C virus protein expression [J]. Biochem Pharmacol, 2014, 89(4): 545-556.
8Raz A, Lev N, Orbach-Zinger S, Djaldetti R, et al. Safety of perioperative treatment with intravenous amantadine in patients with Parkinson disease [J]. Clin Neuropharmacol, 2013, 36(5): 166-169.
9Cheliapina MV, Sharova EV, Za?tsev OS. Clinical and elec- troencephalographic effects of amantadine sulfate(PK-Merz) on consciousness disorders due to the severe traumatic brain injury [J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2011, 111 (5): 24-29.
10Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhance- ment of arousal and cognition after traumatic brain injur [J]. Ann Pharmacother, 2008, 42(2): 247-252.
